Cytogens (Synthesized peptides)

Cytogens are synthesized peptide bioregulators obtained by synthesizing 2-4 amino acids from raw materials of plant origin. As a result, they are a copy of the working part of the most active section of the peptide from the entire complex contained in the extract, that is, one shortened molecule - a nano-peptide.

Physiologically active short nano-peptides are advisable to use at any age to maintain a normal level of metabolic processes, prevent and treat various diseases, rehabilitation after serious illnesses, injuries, operations, and slow down the aging process in the body.

The drugs act at the cellular level, eliminating pathology by restoring metabolic processes characteristic of a young, healthy body. Thus, the regeneration process starts naturally without the use of chemical stimulants.

Due to their ultra-short structure, synthesized Cytogen peptides have a faster effect, although less long-term than natural ones. Therefore, it is advisable to use synthesized Cytogen peptides in the initial stages of diseases, since they quickly initiate the process of primary restoration of normal functions of internal organs, and use them for short repeated courses of prevention. In the future, to continue the positive dynamics in therapy, it is recommended to take Cytomax.

The main difference between Cytogens is that they contain only the most shortened copies of the main, but only, regulatory peptide, while Cytomax contains the entire spectrum that regulates the functioning of the cells of an organ or tissue. The effect obtained from Cytomax is significantly stronger than from Cytogen. Cytomaxes have a longer prolongation of action (up to 5 months), versus 2-3 months for Cytogens. However, the launch speed of Cytogens is higher, because the Cytogen chain is shorter, then with the same dosage in the capsule, their concentration is 10-15 times higher. The advantages of Cytogens also include the rate of accumulation at the same dosages, which is 20%-30% higher in comparison with Cytomaxes and a lower price. As a result, drugs containing Cytogens provide faster but less effective results compared to Cytomaxes. In some situations, launch speed plays a significant role, for example when used in cosmetics, or in combination with certain additives or active substances. And also in complex treatment regimens for various pathologies.

Due to the impossibility of artificially recreating natural types of peptides for all organs, currently only 6 types of synthesized peptide bioregulators have been developed. They are absolutely safe and recognized throughout the world.